Provided by Tiger Trade Technology Pte. Ltd.

Teva Pharmaceutical

36.44
-1.1800-3.14%
Post-market: 36.34-0.1000-0.27%19:55 EDT
Volume:3.14M
Turnover:115.07M
Market Cap:42.45B
PE:60.73
High:37.42
Open:37.37
Low:36.37
Close:37.62
52wk High:38.37
52wk Low:17.94
Shares:1.17B
Float Shares:1.09B
Volume Ratio:0.70
T/O Rate:0.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.6000
EPS(LYR):1.21
ROE:9.69%
ROA:5.13%
PB:5.48
PE(LYR):30.12

Loading ...

Teva to advance TEV-‘408 into Phase 2b study in vitiligo in Q4

TIPRANKS
·
Jul 07

Teva - Tev-’408 Shows Improved Skin Pigmentation and no Safety Signals in Phase 1B

THOMSON REUTERS
·
Jul 07

Teva call volume above normal and directionally bullish

TIPRANKS
·
Jul 07

Teva call volume above normal and directionally bullish

TIPRANKS
·
Jul 02

Lowe’s, Kraft Heinz, Teva, Take-Two, HIVE Insider Shock

TIPRANKS
·
Jun 27

Teva Pharmaceutical Industries (TEVA) Stock Could Be 23.7% Undervalued After Recent Pullback

Simply Wall St.
·
Jun 22

FDA Seeks Updated Labeling for Testosterone Therapies

MT Newswires Live
·
Jun 19

Teva Submits New Drug Application for Ecopipam to Treat Pediatric Tourette Syndrome

MT Newswires Live
·
Jun 19

Teva submits NDA for Ecopipam to FDA

TIPRANKS
·
Jun 19

Teva Releases Q2 2026 Aide Memoire

THOMSON REUTERS
·
Jun 19

Teva - Ecopipam Showed Statistically Significant Benefit on Primary Efficacy Endpoint in Pediatric Patients

THOMSON REUTERS
·
Jun 19

Jefferies continues to like Teva after recent pullback

TIPRANKS
·
Jun 19

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jun 15

How Investors Are Reacting To Teva (TEVA) AUSTEDO Real‑World Data On Tardive Dyskinesia Improvement

Simply Wall St.
·
Jun 11

Analysts Offer Insights on Healthcare Companies: Merit Medical Systems (MMSI), Teva Pharmaceutical (TEVA) and Nuvation Bio (NUVB)

TIPRANKS
·
Jun 10

Teva put volume heavy and directionally bearish

TIPRANKS
·
Jun 09

Teva presents positive long-term study data for Austedo

TIPRANKS
·
Jun 08

Teva’s Data on Austedo® (Deutetrabenazine) Tablets and Austedo Xr® (Deutetrabenazine) Extended-Release Tablets Highlight Long-Term Advances in Tardive Dyskinesia Treatment and Care

THOMSON REUTERS
·
Jun 08

Alvotech Says FDA Agreed to Review Application for Biosimilar of Entyvio; Shares Rise Pre-Bell

MT Newswires Live
·
Jun 08

Teva Says AUSTEDO Improves Quality of Life in Huntington's Disease Study

MT Newswires Live
·
Jun 06